Zrepag 1mg Tablet

Zrepag 1mg Tablet is used to lower blood sugar levels in adults with type 2 diabetes mellitus. It is usually prescribed along with other diabetes medicines to achieve adequate blood sugar control. It also prevents serious complications of diabetes like kidney damage and blindness.

Zrepag 1mg Tablet is normally prescribed when diet and exercise alone or other medicines have not been enough to control your blood sugar level. It works best when taken before meals. The dose will depend on your condition, and blood sugar levels, but you should take it as advised by your doctor.

Take Zrepag 1mg Tablet regularly, at the same time each day, to get the most benefit and you should not stop unless your doctor recommends it. It is controlling your blood sugar levels and helping to prevent serious complications in the future. It is important to stay on the diet and exercise program recommended by your doctor while taking this medicine. Your lifestyle plays a big part in controlling diabetes.

The most common side effect of taking this medicine is hypoglycemia (low blood sugar levels). You can carry sugar or glucose candy to control low blood sugar levels. Other common side effects that may be seen while taking this medicine include abdominal pain and diarrhea. Contact your doctor if the side effects worry you or if they do not go away.

Before taking this medicine, let your doctor know if you have ever had kidney disease, heart or pancreas problems, or if you drink a lot of alcohol. Pregnant or breastfeeding women should also consult their doctor before taking it. Some other medicines you are taking may interfere with it so make sure your doctor knows about all the other medicines you are taking. Limit your alcohol intake while taking this medicine because it can increase your risk of developing low blood sugar levels. You may need regular tests such as kidney function and blood glucose levels to check that the medicine is working properly.

• Treatment of Type 2 diabetes mellitus

Treatment of Type 2 diabetes mellitus
Zrepag 1mg Tablet increases the amount of insulin your body produces (in the pancreas). The insulin then works to lower your blood glucose levels and prevents them from rising after taking meals. You should keep taking it for as long as it is prescribed.

Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Reepag

• Upper respiratory tract infection
• Headache
• Hypoglycemia (low blood glucose level)

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Zrepag 1mg Tablet is to be taken empty stomach.

Zrepag 1mg Tablet is an anti-diabetic medication. It increases the amount of insulin released by the pancreas which prevents blood glucose from rising very high after meals.

• For best results, take Zrepag 1mg Tablet 15 to 30 minutes before a meal.

• You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Zrepag 1mg Tablet

• It may cause dizziness. Do not drive or do anything that requires mental focus until you know how Zrepag 1mg Tablet affects you.

• It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.

• Always carry some sugary food or fruit juice with you in case you experience hypoglycemic symptoms such as cold sweats, cool pale skin, tremor, and anxiety.

• Monitor your blood sugar levels regularly while you are taking this medicine.

• Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.

Powers AC, D’Alessio D. Endocrine Pancreas and Pharmacotherapy of Diabetes Mellitus and Hypoglycemia. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1257.

Nolte MS. Pancreatic hormones and antidiabetic drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 740-41.

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1206-207.

Repaglinide. Gatwick, West Sussex: Novo Nordisk Limited; 2001 [revised May 2016]. [Accessed 28 Jan. 2019] (online) Available from:

Repaglinide. Bagsværd, Denmark: Novo Nordisk A/S; 2015. [Accessed 13 Mar. 2019] (online) Available from:

Repaglinide [Product Monograph]. Ontario, Canada: Novo Nordisk Canada Inc.; 2015. [Accessed 4 Oct. 2021] (online) Available from:

DailyMed. Repaglinide [Prescription Drug Label]. [Accessed 4 Oct. 2021] (online) Available from:

Repaglinide [Summary of Product Characteristics]. Debrecen, Hungary: Teva Pharmaceutical Works Private Limited Company; 2014. [Accessed 4 Oct. 2021] (online) Available from:

Milner Z, Akhondi H. Repaglinide. [Updated 2021 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. Available from:

Repaglinide [Product Information]. [Accessed 4 Oct. 2021] (online) Available from: